FARSHID BOZORGNIA

Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology COLTON, CA NPI 1922493220

General Payments — all program years on this page

$3,244.20

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 107
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,565.70 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Travel and Lodging $854.782
Food and Beverage $710.9212

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
AstraZeneca UK Limited $1,039.114
Amgen Inc. $243.023
UCB SA $140.984
NOVARTIS PHARMACEUTICALS CORPORATION $86.002
UCB, Inc. $56.591

By program year

Program yearAmountRecords
2019 $87.641
2020 $68.804
2021 $992.9679
2022 $123.354
2023 $405.755
2024 $1,565.7014

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086743137 Novartis Pharmaceuticals Corporation $41.00 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086743147 Novartis Pharmaceuticals Corporation $45.00 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093941223 AstraZeneca UK Limited $626.78 06/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1093958355 AstraZeneca UK Limited $49.35 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093994096 AstraZeneca UK Limited $228.00 06/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1094020576 AstraZeneca UK Limited $134.98 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111534866 Amgen Inc. $124.51 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111534868 Amgen Inc. $85.00 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113951101 UCB SA $20.41 10/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113951103 UCB SA $20.57 10/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113951105 UCB SA $50.00 10/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113951107 UCB SA $50.00 10/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117208481 Amgen Inc. $33.51 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143057552 UCB, Inc. $56.59 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.